Амбулаторная хирургия (Jun 2017)
Application of phlebotropic therapy. A review of current clinical practice in Russia
Abstract
The current understanding of the development and course of pathological processes in chronic vascular diseases implies a widespread use of medications. Medications that are pathogenetically substantiated and have a good evidence base for their effectiveness are considered the most appropriate. With regard to chronic venous diseases, product files for drugs containing dios-min and its derivatives are the most complete. This group of drugs enjoys the most extensive and reliable scientific evidence. Pathogenetic value of these medications has been studied, and data was obtained in relation to clinical manifestations of chronic venous diseases (CVDs) and symptoms of chronic venous insufficiency (CVI). These studies are of fundamental importance in understanding the pathophysiological processes, and they continue today enriching the treasury of research.